Atai Life Sciences
ATAI
#8096
Rank
$0.17 B
Marketcap
$1.06
Share price
-5.36%
Change (1 day)
-13.82%
Change (1 year)

P/E ratio for Atai Life Sciences (ATAI)

P/E ratio as of October 2024 (TTM): -1.15

According to Atai Life Sciences's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.15217. At the end of 2022 the company had a P/E ratio of -2.71.

P/E ratio history for Atai Life Sciences from 2021 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-2.71-57.47%
2021-6.38

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.